Semisolid Formulation Development: The CRO Approach - SP Formulations Whitepaper

The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.